American International Group’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q3
Sell
-90,394
Closed -$16.6K 3169
2021
Q2
$16.6K Sell
90,394
-1,709
-2% -$314 0.06% 281
2021
Q1
$14.1K Sell
92,103
-2,303
-2% -$352 0.05% 342
2020
Q4
$14.8K Sell
94,406
-311
-0.3% -$49 0.05% 293
2020
Q3
$10.8M Sell
94,717
-3,643
-4% -$417K 0.05% 316
2020
Q2
$11M Buy
98,360
+1,058
+1% +$119K 0.05% 297
2020
Q1
$8.74M Sell
97,302
-1,056
-1% -$94.8K 0.05% 336
2019
Q4
$10.6M Buy
98,358
+2,242
+2% +$242K 0.04% 399
2019
Q3
$9.41M Sell
96,116
-490
-0.5% -$48K 0.04% 446
2019
Q2
$12.7M Sell
96,606
-2,150
-2% -$282K 0.05% 291
2019
Q1
$13.4M Sell
98,756
-394
-0.4% -$53.3K 0.05% 274
2018
Q4
$9.65M Sell
99,150
-5,060
-5% -$493K 0.04% 349
2018
Q3
$14.5M Buy
104,210
+5,079
+5% +$706K 0.05% 251
2018
Q2
$12.3M Buy
99,131
+125
+0.1% +$15.5K 0.04% 282
2018
Q1
$11M Sell
99,006
-1,890
-2% -$211K 0.04% 349
2017
Q4
$12.1M Buy
100,896
+1,499
+2% +$179K 0.04% 325
2017
Q3
$13.9M Sell
99,397
-4,124
-4% -$579K 0.05% 226
2017
Q2
$12.6M Buy
103,521
+1,015
+1% +$123K 0.04% 253
2017
Q1
$12.4M Buy
102,506
+268
+0.3% +$32.5K 0.05% 263
2016
Q4
$12.5M Sell
102,238
-1,433
-1% -$175K 0.05% 246
2016
Q3
$12.7M Buy
103,671
+795
+0.8% +$97.4K 0.05% 215
2016
Q2
$12M Buy
102,876
+6,029
+6% +$704K 0.05% 224
2016
Q1
$13.5M Sell
96,847
-1,294
-1% -$180K 0.05% 226
2015
Q4
$18.7M Buy
98,141
+1,203
+1% +$229K 0.08% 146
2015
Q3
$15.2M Buy
96,938
+859
+0.9% +$134K 0.07% 173
2015
Q2
$17.4M Buy
96,079
+6,394
+7% +$1.16M 0.07% 168
2015
Q1
$15.5M Buy
89,685
+4,814
+6% +$834K 0.06% 198
2014
Q4
$15.7M Sell
84,871
-1,199
-1% -$222K 0.07% 176
2014
Q3
$14.3M Buy
86,070
+1,300
+2% +$216K 0.06% 196
2014
Q2
$13.2M Sell
84,770
-5,412
-6% -$846K 0.06% 234
2014
Q1
$13.7M Sell
90,182
-896
-1% -$136K 0.06% 197
2013
Q4
$12.1M Sell
91,078
-454
-0.5% -$60.4K 0.06% 226
2013
Q3
$10.6M Buy
91,532
+2,844
+3% +$330K 0.06% 264
2013
Q2
$8.18M Buy
+88,688
New +$8.18M 0.05% 361